Lilly makes changes to global manufacturing operations

摘要

Eli Lilly has announced changes to its global manufacturing operations: a US plant will be closed but the firm will invest in other parts of the US and Ireland. Scott Canute, Lilly's president of manufacturing operations, said that Lilly continues to expect growing worldwide demand for its insulin products and insulin delivery devices, but not at levels projected when plans for the Prince William County, Virginia, US site were put in place in 2003. Construction on the site will stop immediately.